December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
M-Pathway Deficits in Schizophrenia: VEPS, Contrast Sensitivity and Functional Outcome
Author Affiliations & Notes
  • I Schechter
    Program in Cognitive Neuroscience and Schizophrenia Nathan S Kline Institute for Psychiatric Research Orangeburg NY
  • PD Butler
    Program in Cognitive Neuroscience and Schizophrenia Nathan S Kline Institute for Psychiatric Research Orangeburg NY
  • N Revheim
    Program in Cognitive Neuroscience and Schizophrenia Nathan S Kline Institute for Psychiatric Research Orangeburg NY
  • AM Saperstein
    Program in Cognitive Neuroscience and Schizophrenia Nathan S Kline Institute for Psychiatric Research Orangeburg NY
  • G Silipo
    Program in Cognitive Neuroscience and Schizophrenia Nathan S Kline Institute for Psychiatric Research Orangeburg NY
  • VM Zemon
    Ferkauf Graduate School of Psychology Yeshiva University Bronx NY
  • DC Javitt
    Program in Cognitive Neuroscience and Schizophrenia Nathan S Kline Institute for Psychiatric Research Orangeburg NY
  • Footnotes
    Commercial Relationships   I. Schechter, None; P.D. Butler, None; N. Revheim, None; A.M. Saperstein, None; G. Silipo, None; V.M. Zemon, None; D.C. Javitt, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 1810. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      I Schechter, PD Butler, N Revheim, AM Saperstein, G Silipo, VM Zemon, DC Javitt; M-Pathway Deficits in Schizophrenia: VEPS, Contrast Sensitivity and Functional Outcome . Invest. Ophthalmol. Vis. Sci. 2002;43(13):1810.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Patients with schizophrenia demonstrate deficits of visual processing. We investigated Magnocellular (M) and Parvocellular (P) function using transient and steady-state VEPs (tVEPs and ssVEPs) in addition to contrast sensitivity testing. We then examined the relationship of M and P function and functional outcome. Methods: tVEPs were elicited by checkerboards contrast-reversed at 1 Hz. Either luminance contrast (4% and 100%) or red/green chromatic contrast (100%) were used. ssVEPs were elicited by arrays of isolated checks modulated sinusoidally at 12 Hz with luminance varied parametrically in 1-s steps. Appearance-disappearance and pedestal contrast conditions were used to emphasize M and P activity, respectively. Contrast sensitivity was measured over a range of spatial frequencies (0.5, 1, 2, 4,7, 11, 21 cycles/degree) and determined by forced choice. All controls and patients with schizophrenia were age-matched. Functional outcome was assessed using the problem-solving factor of the Independent Living Scales (ILS-PB). Results: tVEPs to high and low (100% and 4%) achromatic contrasts were significantly reduced in patients with schizophrenia as compared with controls, whereas tVEPs to chromatic contrast checkerboards were not significantly different. ssVEPs to M-biased low luminance contrast stimuli were preferentially decreased in amplitude, whereas P-biased responses were relatively unaffected. Further, contrast sensitivity of patients with schizophrenia to M-biased low spatial frequency stimuli was depressed as compared with controls but sensitivity to P-biased high spatial frequency stimuli were intact. Significant positive correlations were found between ILS-PB scores and M-biased VEPs (tVEPs of 4% achromatic contrast and ssVEPs to low luminance contrast) but not P-biased VEP conditions. Contrast sensitivity at the lowest spatial frequency (0.5 c/deg) correlated with M-biased tVEPs and ssVEPs, as well as with ILS-PB scores. M-biased tVEPs (4% contrast) and M-biased ssVEPs were also significantly correlated. Conclusion: These results indicate a preferential dysfunction of low level M visual pathway which is related to poor functional outcome in schizophrenia.

Keywords: 393 electrophysiology: clinical • 625 visual impairment: neuro-ophthalmological disease • 368 contrast sensitivity 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×